Ochratoxin A exposure biomarkers in the Czech Republic and comparison with foreign countries

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F75010330%3A_____%2F12%3A00009739" target="_blank" >RIV/75010330:_____/12:00009739 - isvavai.cz</a>
Alternative codes found
RIV/62690094:18470/12:50002978
Result on the web
<a href="http://informahealthcare.com/doi/abs/10.3109/1354750X.2012.692392" target="_blank" >http://informahealthcare.com/doi/abs/10.3109/1354750X.2012.692392</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3109/1354750X.2012.692392" target="_blank" >10.3109/1354750X.2012.692392</a>

Result language
angličtina
Original language name
Ochratoxin A exposure biomarkers in the Czech Republic and comparison with foreign countries
Original language description
OTA is nephrotoxic, hepatotoxic, teratogenic and immunotoxic mycotoxin. OTA exposure may lead to formation of DNA adducts resulting to genotoxicity and carcinogenicity (human carcinogen of 2B group). Now it seems that OTA could be "a complete carcinogen"which obliges to monitor its presence in biological materials, especially using the suitable biomarkers. In this article, OTA findings in urine, blood, serum, plasma and human kidneys (target dose) in the Czech Republic and comparison with foreign countries are presented.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FQ - Public health system, social medicine
OECD FORD branch
—

Project
<a href="/en/project/NT12051" target="_blank" >NT12051: Ochratoxin A ? health risk assessment for selected population groups in the Czech Republic</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)